Undervalued U.S. Cannabis Stocks to Add to Your Q2 Watchlist
The U.S. cannabis industry continues to show strong momentum, with projections estimating the market will reach over $45 billion in 2025. This rapid growth is fueled by expanding legalization and widespread consumer demand. Nearly half of Americans have tried cannabis, and most now live near at least one dispensary. Moreover, the industry supports hundreds of thousands of full-time jobs, making it a major contributor to the U.S. economy. However, recent headlines indicate that federal cannabis reform may be delayed. Lawmakers remain divided, and the White House has not announced any immediate plans to reschedule marijuana. Even so, optimism remains high as more states push for legalization in 2025.
Because cannabis stocks are often volatile, traders should rely on technical analysis to guide their strategies. Chart patterns, support and resistance levels, and moving averages can help identify potential entry points. However, managing risk is equally important. Investors should set stop-loss orders and size positions appropriately. Diversification also reduces exposure to individual stock swings. Staying updated on market news and federal policy developments is crucial. In this evolving sector, success depends on discipline, research, and patience.
As the cannabis sector continues to gain traction, certain U.S.-based companies will stand out in April 2025. Three leading operators—Curaleaf Holdings Inc. (CURLF), Cresco Labs Inc. (CRLBF), and Ayr Wellness Inc. (AYRWF)—are gaining investor attention due to their scale, strategy, and financial strength. Each has carved out a significant share of the U.S. cannabis market and continues to position for long-term growth. Let’s take a closer look at these three top marijuana stocks.
[Read More] 3 Marijuana Stocks That Could Be Top Market Performers
Q2 2025 Cannabis Watchlist: U.S. Stocks With Upside Potential
- Curaleaf Holdings Inc. (OTC: CURLF)
- Cresco Labs Inc. (OTC: CRLBF)
- Ayr Wellness Inc. (OTC: AYRWF)
Curaleaf Holdings Inc. (CURLF)
Curaleaf Holdings Inc. remains one of the largest cannabis operators in the United States. The company operates in 23 states and has more than 130 dispensaries nationwide. Its wide reach allows it to serve both medical and recreational customers across multiple regions. Curaleaf’s largest market presence is in Florida, with dozens of dispensary locations. These locations cater to a fast-growing patient base and benefit from rising cannabis demand in the state. In addition, Curaleaf is expanding internationally, but its U.S. footprint remains its core revenue driver.
The company continues strengthening its brand through new product launches and a focus on customer service. It offers a wide selection of flower, vapes, edibles, and wellness products. Each location is designed to give customers a consistent, informative, and safe shopping experience. Over time, Curaleaf has built strong relationships with patients and adult-use consumers alike. It has also invested heavily in cultivation and production to support long-term growth. Because of its size and reputation, it remains a major player to watch.
In its most recent earnings report, Curaleaf reported revenue of $331.1 million for the fourth quarter of 2024. This marked a 4% decline compared to the prior year’s fourth quarter. However, gross profit was $157.4 million, showing a year-over-year margin improvement. For the full year 2024, revenue totaled $1.34 billion, remaining flat compared to 2023. International revenue rose sharply, increasing by over 70% year-over-year.
The company’s adjusted EBITDA remained stable, supported by cost controls and margin improvements. Despite a small drop in sales, Curaleaf made operational progress that strengthened its profitability. It ended the year with strong liquidity and continues to reduce costs while driving product innovation. Curaleaf’s balance between growth and financial discipline positions it well for 2025.
[Read More] Undervalued U.S. Cannabis Penny Stocks to Add to Your Watchlist
Cresco Labs Inc. (CRLBF)
Cresco Labs Inc. is a major vertically integrated cannabis company with operations across several key U.S. states. The company’s retail segment operates under the Sunnyside brand. It currently owns and manages 71 dispensaries across six states. These retail stores focus on consumer education, product accessibility, and a modern shopping experience. Cresco also emphasizes e-commerce and online ordering to streamline customer transactions. Its operations span major markets like Illinois, Pennsylvania, and Ohio.
Cresco is especially known for its strong portfolio of cannabis brands. These include products in the flower, concentrate, edible, and vape categories. The company focuses on brand loyalty and has consistently increased its share in high-volume retail states. Through vertical integration, Cresco controls the entire supply chain. This allows for consistency, efficiency, and better margins. In recent years, Cresco has sharpened its business model to emphasize profitability over expansion.
In its 2024 financial results, Cresco reported a total revenue of $724 million, which was down 6% year-over-year. However, the company improved its gross margin to 52%, up 270 basis points from the previous year. This margin growth highlights successful cost management and efficiency gains. Cresco also reported $132 million in operating cash flow, a 126% increase from 2023. Free cash flow came in at $114 million, showing strong financial discipline.
The company maintained solid liquidity and worked to reduce debt obligations over time. Operating expenses were tightly managed, and capital expenditures were cut significantly. Despite a dip in total revenue, Cresco exited 2024 with improved profitability and cash flow. These results show that the company’s focus on fundamentals is paying off. Heading into 2025, Cresco is positioned for long-term strength in a competitive market.
[Read More] Top Canadian Cannabis Stocks to Watch in April 2025
Ayr Wellness Inc. (AYRWF)
Ayr Wellness Inc. is a multi-state cannabis operator focused on building strong regional businesses. The company has a presence in seven U.S. states, including major markets like Florida, Massachusetts, Pennsylvania, and New Jersey. It operates more than 60 dispensaries in Florida alone. Ayr Cannabis Dispensary operates these locations and actively serves medical marijuana patients across the state. Florida remains Ayr’s strongest market, where it has developed deep local customer relationships.
The company provides a full range of cannabis products, including flower, concentrates, vapes, and wellness items. Ayr focuses on delivering excellent service and high-quality products. It has invested heavily in cultivation and processing facilities to support vertical integration. The brand experience is personalized and patient-focused, especially in medical markets. With a combination of retail stores and backend infrastructure, Ayr is building long-term value across its operational footprint.
For the fourth quarter of 2024, Ayr reported $114 million in revenue. This was flat compared to the previous quarter and slightly down from the prior year. The company’s adjusted gross margin was 49%, showing consistent cost performance. Adjusted EBITDA for the quarter was $19.1 million, resulting in a margin of 16.7%. These figures reflect disciplined operations and tight expense management.
Ayr finished the year with a cash balance of $35.5 million. Although this was lower than the previous quarter, the company still generated $9.6 million in operating cash flow for the full year. It also continued to streamline operations and exit underperforming markets. The focus remains on core markets, profitability, and operational efficiency. Ayr’s leadership has emphasized sustainable growth heading into 2025.
Best U.S. Marijuana Stocks to Trade This Spring Season
Curaleaf, Cresco Labs, and Ayr Wellness are three standout cannabis stocks for April 2025. Each company operates at scale, manages a strong retail footprint, and is improving its financial discipline. While the broader cannabis market faces regulatory uncertainty, these companies are building solid foundations. Investors watching the sector should consider these names for their proven track records and potential upside as reform evolves
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
